keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RNAIII-inhibiting peptide TFA (RNAIII-inhibiting peptide(TFA))(228544-21-6 free base) inhibits S. aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 186.00 | |
5 mg | In stock | $ 598.00 | |
10 mg | In stock | $ 778.00 | |
25 mg | In stock | $ 1,010.00 | |
50 mg | In stock | $ 1,310.00 | |
100 mg | In stock | $ 1,710.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 788.00 |
Description | RNAIII-inhibiting peptide TFA (RNAIII-inhibiting peptide(TFA))(228544-21-6 free base) inhibits S. aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis. |
In vitro | The RNAIII inhibiting peptide (RIP) is able to inhibit S. aureus pathogenesis by disrupting QS mechanism competing with RAP, thus inhibiting the phosphorylation of TRAP. This alteration leads to a reduced adhesion and to the inhibition of RNAIII synthesis, with the subsequent suppression of toxins synthesis. |
Synonyms | RNAIII-inhibiting peptide(TFA) |
Molecular Weight | 1027.01 |
Formula | C47H57F3N10O13 |
CAS No. | TP1412 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (146.06 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RNAIII-inhibiting peptide TFA TP1412 Microbiology/Virology Antibacterial RNAIII-inhibiting peptide(TFA) RNAIII inhibiting peptide TFA RNAIIIinhibiting peptide TFA inhibitor inhibit